Profiel
Graeme Fraser is currently the Chief Scientific Officer at Ogeda SA. Previously, he worked as a Principal at AstraZeneca Canada, Inc. and Viron Therapeutics, Inc. He also served as the Vice President-Drug Discovery at Tranzyme Pharma, Inc. (Canada).
Dr. Fraser holds a doctorate degree from McGill University.
Actieve functies van Graeme Fraser
| Bedrijven | Functie | Begin |
|---|---|---|
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Graeme Fraser
| Bedrijven | Functie | Einde |
|---|---|---|
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Corporate Officer/Principal | - |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Corporate Officer/Principal | - |
Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | - |
Opleiding van Graeme Fraser
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Health Technology |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Health Technology |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Tranzyme Pharma, Inc. (Canada) |
















